Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06132386 · ClinicalTrials.gov registry record
Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 21
- Enrollment target
NCT06132386: Completed study, sponsored by Johns Hopkins University.
NCT06132386 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06132386 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical study is to learn about the effect of aging on certain enzymes, or proteins, in the blood and colon. The study involves collection of blood and colon tissue biopsies using a flexible sigmoidoscope or colonoscope. This study is also investigating how medications tenofovir and emtricitabine interact with certain enzymes. The investigators will compare the difference in enzyme activity between people taking tenofovir and emtricitabine, to those who are not taking tenofovir and emtricitabine.
Primary Outcome
Concentration in nanometers (nm) of AK2 in colorectal tissue.
Interventions
- OTHER biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-08-07 |
| Est. Completion | 2024-05-20 |
What the finished NCT06132386 record still lists
NCT06132386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which biopsy is the first listed.
NCT06132386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06132386 about?
NCT06132386 is a clinical study titled "Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue". The goal of this clinical study is to learn about the effect of aging on certain enzymes, or proteins, in the blood and colon. The study involves collection of blood and colon tissue biopsies using a flexible sigmoidoscope or colonoscope. This study is also investigating how medications tenofovir an...
What is the current status of trial NCT06132386?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2023-08-07. Estimated completion is 2024-05-20.
What interventions are being tested in trial NCT06132386?
The interventions under investigation include: biopsy (OTHER).
Who is sponsoring clinical trial NCT06132386?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI